The Consumers Health Forum of Australia (CHF) is pleased to provide a submission to the Issues Paper for the Post-Market Review of the Life-Saving Drugs Programme (the Issues Paper). Before going into the content of our views, we want to express our deep concerns with the limitations the Review has given to stakeholders to comment on the Issues Paper.